First Time Loading...

Eyebright Medical Technology Beijing Co Ltd
SSE:688050

Watchlist Manager
Eyebright Medical Technology Beijing Co Ltd Logo
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Watchlist
Price: 141.6 CNY -0.94% Market Closed
Updated: May 29, 2024

Balance Sheet

Balance Sheet Decomposition
Eyebright Medical Technology Beijing Co Ltd

Current Assets 1.1B
Cash & Short-Term Investments 733.2m
Receivables 168.4m
Other Current Assets 166.9m
Non-Current Assets 1.3B
Long-Term Investments 160.1m
PP&E 868.5m
Intangibles 168.6m
Other Non-Current Assets 92.9m
Current Liabilities 120.6m
Accounts Payable 19m
Accrued Liabilities 33.7m
Other Current Liabilities 67.9m
Non-Current Liabilities 253.3m
Long-Term Debt 171.2m
Other Non-Current Liabilities 82.2m

Balance Sheet
Eyebright Medical Technology Beijing Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
31
67
196
537
473
355
Cash
0
0
0
0
473
350
Cash Equivalents
31
67
196
537
0
5
Short-Term Investments
0
203
0
453
485
482
Total Receivables
43
50
67
88
90
118
Accounts Receivables
35
45
58
74
68
104
Other Receivables
8
5
9
14
22
15
Inventory
17
36
61
59
56
79
Other Current Assets
6
6
11
9
15
27
Total Current Assets
96
362
335
1 146
1 119
1 061
PP&E Net
95
138
202
286
604
795
PP&E Gross
95
138
202
286
604
795
Accumulated Depreciation
14
22
36
52
79
112
Intangible Assets
56
57
101
113
128
140
Goodwill
0
0
0
0
21
21
Long-Term Investments
16
15
16
41
101
151
Other Long-Term Assets
14
15
33
53
75
76
Other Assets
0
0
0
0
21
21
Total Assets
276
N/A
587
+112%
686
+17%
1 639
+139%
2 048
+25%
2 245
+10%
Liabilities
Accounts Payable
0
0
0
2
6
14
Accrued Liabilities
7
10
14
18
32
43
Short-Term Debt
10
0
0
0
0
0
Current Portion of Long-Term Debt
0
6
0
0
0
0
Other Current Liabilities
21
8
9
57
102
91
Total Current Liabilities
38
24
23
77
139
148
Long-Term Debt
28
0
0
0
155
163
Deferred Income Tax
0
0
0
0
1
4
Minority Interest
0
3
30
30
66
60
Other Liabilities
11
9
15
14
12
10
Total Liabilities
78
N/A
36
-54%
68
+92%
120
+77%
374
+210%
384
+3%
Equity
Common Stock
61
79
79
105
105
105
Retained Earnings
29
9
11
108
250
444
Additional Paid In Capital
167
481
528
1 305
1 318
1 311
Total Equity
198
N/A
551
+178%
618
+12%
1 518
+146%
1 674
+10%
1 860
+11%
Total Liabilities & Equity
276
N/A
587
+112%
686
+17%
1 639
+139%
2 048
+25%
2 245
+10%
Shares Outstanding
Common Shares Outstanding
61
79
79
105
105
105

See Also

Discover More